To demonstrate the mitochondrial reprogramming influenced by MYC overexpression in progressed MM cells, and its potential as a therapeutic target, we used the antibiotic tigecycline, which inhibits protein synthesis in both bacterial and mitochondria-encoded proteins, due to the similarity of mitochondrial and bacterial ribosomes [37]. This evidence concerns the gene MYC and Miyoshi myopathy.